N-[5-fluoro-7-hydroxy-6-(1,1,4-trioxo-1,2,5-thiadiazolidin-2-yl)naphthalen-2-yl]-2-[2-fluoro-4-[1-[2-[(2R)-3-methylbutan-2-yl]-6-oxopiperidin-3-yl]-2-oxo-3H-benzimidazol-5-yl]phenyl]acetamide

C37H36F2N6O7S — CID 156517298

IUPACN-[5-fluoro-7-hydroxy-6-(1,1,4-trioxo-1,2,5-thiadiazolidin-2-yl)naphthalen-2-yl]-2-[2-fluoro-4-[1-[2-[(2R)-3-methylbutan-2-yl]-6-oxopiperidin-3-yl]-2-oxo-3H-benzimidazol-5-yl]phenyl]acetamide
SMILESCC(C)[C@@H](C)C1NC(=O)CCC1n1c(=O)[nH]c2cc(-c3ccc(CC(=O)Nc4ccc5c(F)c(N6CC(=O)NS6(=O)=O)c(O)cc5c4)c(F)c3)ccc21
InChIInChI=1S/C37H36F2N6O7S/c1-18(2)19(3)35-29(10-11-31(47)42-35)45-28-9-6-21(14-27(28)41-37(45)50)20-4-5-22(26(38)13-20)16-32(48)40-24-7-8-25-23(12-24)15-30(46)36(34(25)39)44-17-33(49)43-53(44,51)52/h4-9,12-15,18-19,29,35,46H,10-11,16-17H2,1-3H3,(H,40,48)(H,41,50)(H,42,47)(H,43,49)/t19-,29?,35?/m1/s1
InChIKeyDPEGLOUFTBPBCX-CGWXXEPBSA-N
MW746.79 g/mol
LogP4.61
Rot. Bonds8

About N-[5-fluoro-7-hydroxy-6-(1,1,4-trioxo-1,2,5-thiadiazolidin-2-yl)naphthalen-2-yl]-2-[2-fluoro-4-[1-[2-[(2R)-3-methylbutan-2-yl]-6-oxopiperidin-3-yl]-2-oxo-3H-benzimidazol-5-yl]phenyl]acetamide

N-[5-fluoro-7-hydroxy-6-(1,1,4-trioxo-1,2,5-thiadiazolidin-2-yl)naphthalen-2-yl]-2-[2-fluoro-4-[1-[2-[(2R)-3-methylbutan-2-yl]-6-oxopiperidin-3-yl]-2-oxo-3H-benzimidazol-5-yl]phenyl]acetamide (PubChem CID 156517298) has the molecular formula C37H36F2N6O7S and a molecular weight of 746.79 g/mol. Its IUPAC name is N-[5-fluoro-7-hydroxy-6-(1,1,4-trioxo-1,2,5-thiadiazolidin-2-yl)naphthalen-2-yl]-2-[2-fluoro-4-[1-[2-[(2R)-3-methylbutan-2-yl]-6-oxopiperidin-3-yl]-2-oxo-3H-benzimidazol-5-yl]phenyl]acetamide.

Molecular Properties

Compound NameN-[5-fluoro-7-hydroxy-6-(1,1,4-trioxo-1,2,5-thiadiazolidin-2-yl)naphthalen-2-yl]-2-[2-fluoro-4-[1-[2-[(2R)-3-methylbutan-2-yl]-6-oxopiperidin-3-yl]-2-oxo-3H-benzimidazol-5-yl]phenyl]acetamide
PubChem CID156517298
Molecular FormulaC37H36F2N6O7S
Molecular Weight746.79 g/mol
Exact Mass746.23
IUPAC NameN-[5-fluoro-7-hydroxy-6-(1,1,4-trioxo-1,2,5-thiadiazolidin-2-yl)naphthalen-2-yl]-2-[2-fluoro-4-[1-[2-[(2R)-3-methylbutan-2-yl]-6-oxopiperidin-3-yl]-2-oxo-3H-benzimidazol-5-yl]phenyl]acetamide
SMILESCC(C)[C@@H](C)C1NC(=O)CCC1n1c(=O)[nH]c2cc(-c3ccc(CC(=O)Nc4ccc5c(F)c(N6CC(=O)NS6(=O)=O)c(O)cc5c4)c(F)c3)ccc21
InChIInChI=1S/C37H36F2N6O7S/c1-18(2)19(3)35-29(10-11-31(47)42-35)45-28-9-6-21(14-27(28)41-37(45)50)20-4-5-22(26(38)13-20)16-32(48)40-24-7-8-25-23(12-24)15-30(46)36(34(25)39)44-17-33(49)43-53(44,51)52/h4-9,12-15,18-19,29,35,46H,10-11,16-17H2,1-3H3,(H,40,48)(H,41,50)(H,42,47)(H,43,49)/t19-,29?,35?/m1/s1
InChIKeyDPEGLOUFTBPBCX-CGWXXEPBSA-N
XLogP4.61
TPSA182.70 Ų
H-Bond Donors5
H-Bond Acceptors8
Rotatable Bonds8
Heavy Atoms53
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500746.79
LogP ≤ 54.61
H-Bond Donors ≤ 55
H-Bond Acceptors ≤ 108

Analyze N-[5-fluoro-7-hydroxy-6-(1,1,4-trioxo-1,2,5-thiadiazolidin-2-yl)naphthalen-2-yl]-2-[2-fluoro-4-[1-[2-[(2R)-3-methylbutan-2-yl]-6-oxopiperidin-3-yl]-2-oxo-3H-benzimidazol-5-yl]phenyl]acetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[5-fluoro-7-hydroxy-6-(1,1,4-trioxo-1,2,5-thiadiazolidin-2-yl)naphthalen-2-yl]-2-[2-fluoro-4-[1-[2-[(2R)-3-methylbutan-2-yl]-6-oxopiperidin-3-yl]-2-oxo-3H-benzimidazol-5-yl]phenyl]acetamide?
The IUPAC name of N-[5-fluoro-7-hydroxy-6-(1,1,4-trioxo-1,2,5-thiadiazolidin-2-yl)naphthalen-2-yl]-2-[2-fluoro-4-[1-[2-[(2R)-3-methylbutan-2-yl]-6-oxopiperidin-3-yl]-2-oxo-3H-benzimidazol-5-yl]phenyl]acetamide (CID 156517298) is N-[5-fluoro-7-hydroxy-6-(1,1,4-trioxo-1,2,5-thiadiazolidin-2-yl)naphthalen-2-yl]-2-[2-fluoro-4-[1-[2-[(2R)-3-methylbutan-2-yl]-6-oxopiperidin-3-yl]-2-oxo-3H-benzimidazol-5-yl]phenyl]acetamide.
What is the SMILES notation for N-[5-fluoro-7-hydroxy-6-(1,1,4-trioxo-1,2,5-thiadiazolidin-2-yl)naphthalen-2-yl]-2-[2-fluoro-4-[1-[2-[(2R)-3-methylbutan-2-yl]-6-oxopiperidin-3-yl]-2-oxo-3H-benzimidazol-5-yl]phenyl]acetamide?
The canonical SMILES for N-[5-fluoro-7-hydroxy-6-(1,1,4-trioxo-1,2,5-thiadiazolidin-2-yl)naphthalen-2-yl]-2-[2-fluoro-4-[1-[2-[(2R)-3-methylbutan-2-yl]-6-oxopiperidin-3-yl]-2-oxo-3H-benzimidazol-5-yl]phenyl]acetamide is CC(C)[C@@H](C)C1NC(=O)CCC1n1c(=O)[nH]c2cc(-c3ccc(CC(=O)Nc4ccc5c(F)c(N6CC(=O)NS6(=O)=O)c(O)cc5c4)c(F)c3)ccc21.
What is the InChIKey of N-[5-fluoro-7-hydroxy-6-(1,1,4-trioxo-1,2,5-thiadiazolidin-2-yl)naphthalen-2-yl]-2-[2-fluoro-4-[1-[2-[(2R)-3-methylbutan-2-yl]-6-oxopiperidin-3-yl]-2-oxo-3H-benzimidazol-5-yl]phenyl]acetamide?
The InChIKey is DPEGLOUFTBPBCX-CGWXXEPBSA-N. The full InChI is InChI=1S/C37H36F2N6O7S/c1-18(2)19(3)35-29(10-11-31(47)42-35)45-28-9-6-21(14-27(28)41-37(45)50)20-4-5-22(26(38)13-20)16-32(48)40-24-7-8-25-23(12-24)15-30(46)36(34(25)39)44-17-33(49)43-53(44,51)52/h4-9,12-15,18-19,29,35,46H,10-11,16-17H2,1-3H3,(H,40,48)(H,41,50)(H,42,47)(H,43,49)/t19-,29?,35?/m1/s1.
What are the key properties of N-[5-fluoro-7-hydroxy-6-(1,1,4-trioxo-1,2,5-thiadiazolidin-2-yl)naphthalen-2-yl]-2-[2-fluoro-4-[1-[2-[(2R)-3-methylbutan-2-yl]-6-oxopiperidin-3-yl]-2-oxo-3H-benzimidazol-5-yl]phenyl]acetamide?
N-[5-fluoro-7-hydroxy-6-(1,1,4-trioxo-1,2,5-thiadiazolidin-2-yl)naphthalen-2-yl]-2-[2-fluoro-4-[1-[2-[(2R)-3-methylbutan-2-yl]-6-oxopiperidin-3-yl]-2-oxo-3H-benzimidazol-5-yl]phenyl]acetamide has a molecular weight of 746.79 g/mol, XLogP of 4.61, 8 rotatable bonds, 5 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for N-[5-fluoro-7-hydroxy-6-(1,1,4-trioxo-1,2,5-thiadiazolidin-2-yl)naphthalen-2-yl]-2-[2-fluoro-4-[1-[2-[(2R)-3-methylbutan-2-yl]-6-oxopiperidin-3-yl]-2-oxo-3H-benzimidazol-5-yl]phenyl]acetamide is sourced from PubChem (CID 156517298), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).